Jana B Drummond, Micah Simmons, Vahram Haroutunian, James H Meador-Woodruff
Index: Neuroreport 23(17) , 1031-4, (2012)
Full Text: HTML
Schizophrenia has been proposed to be associated with abnormal glutamatergic neurotransmission. The AMPA subtype of glutamate receptors (AMPARs) mediates fast excitatory synaptic transmission in the brain, and their trafficking and function is regulated in part by AMPAR auxiliary proteins including the cornichons (CNIH) and transmembrane AMPAR-regulatory proteins. Abnormal regulation of AMPARs through altered expression of these auxiliary proteins could induce changes in glutamatergic neurotransmission and thus the pathophysiology of schizophrenia. In this study, transcript expression of cornichon homologs 1-4 was measured in the dorsolateral prefrontal cortex from schizophrenia (N=25) and comparison (N=25) patient groups by comparative quantitative real-time PCR. Significant upregulation of CNIH-1, CNIH-2, and CNIH-3 mRNA expression was found in schizophrenia, with no change in CNIH-4 expression. To determine the effect of antipsychotic treatment on the expression of these genes, cornichon mRNA expression was assayed in the frontal cortex of rats treated chronically with haloperidol decanoate and no changes in any of the cornichon transcripts were found. Abnormal expression of the CNIH family of genes is consistent with cornichon-mediated AMPAR trafficking abnormalities in schizophrenia, and suggests a new mechanism contributing toward the pathophysiology of this illness.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidyl decanoate
CAS:74050-97-8 |
C31H41ClFNO3 |
Effectiveness of paliperidone palmitate vs haloperidol decan...
2014-05-21 [JAMA 311(19) , 1978-87, (2014)] |
Maintenance treatment with long-acting injectable antipsycho...
2014-05-21 [JAMA 311(19) , 1973-4, (2014)] |
Ten year outcomes of outpatients with schizophrenia on conve...
2013-09-01 [Int. Clin. Psychopharmacol. 28(5) , 261-6, (2013)] |
Effects of omega-3 essential fatty acids (omega-3 EFAs) on m...
2010-04-01 [Neurotox. Res. 17(3) , 228-37, (2010)] |
Prospective trial of customized adherence enhancement plus l...
2013-12-01 [J. Clin. Psychiatry 74(12) , 1249-55, (2013)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved